B- and T-cell acute lymphoblastic leukemias evade chemotherapy at distinct sites in the bone marrow
Malwine J. Barz(University Children's Hospital Zurich), Jean‐Pierre Bourquin(University Children's Hospital Zurich), César Nombela‐Arrieta(University Hospital of Zurich), Lena Behrmann(University Children's Hospital Zurich), Blerim Marovca(University Children's Hospital Zurich), Fabio D. Steffen(University Children's Hospital Zurich), Moritz Kirschmann(University of Zurich), Antonia T.L. Zech(University Children's Hospital Zurich), Danaëlle Capron(University Children's Hospital Zurich), Gabriele Zuchtriegel(LMU Klinikum), Urs Ziegler(University of Zurich), Leo Kunz(Center for Pediatric Endocrinology Zurich), Timm Schroeder(Helmholtz Zentrum München), Beat Bornhäuser(University Children's Hospital Zurich), Yang Zhang(ETH Zurich), Iria Jimenez Vermeerbergen(University Children's Hospital Zurich)
Cited by 12
Related Papers
Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance
|Journal of Clinical Investigation|2010|311
<i>IKZF1</i><sup>plus</sup>Defines a New Minimal Residual Disease–Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia
|Journal of Clinical Oncology|2018|304